Research Paper Volume 16, Issue 10 pp 8552—8571
Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma
Figure 7. Immunotherapy and drug sensitivity assessment. (A) TIDE score between high- and low-risk groups. (B–E) Riskscore survival curve and immunotherapy distribution in IMvigor210, GSE135222, GSE78220 and GSE91061 datasets. (F) Differential heatmap analysis of 62 chemotherapeutics in high and low riskscore groups. *p < 0.05, **p < 0.01, ***p < 0.001, ***p < 0.0001.